Retatrutide
CAS: 2381272-04-2
Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. Research focuses on its potent effects on metabolic regulation, energy balance, and body weight in preclinical models.
Mol. Weight
4731.40 g/mol
Quantity
20mg
Form
Lyophilized Powder
Storage
Store at -20°C. Protect from light and moisture.
Amino Acid Sequence
His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg
Research Applications
Metabolic disorder research, obesity models, glucose homeostasis studies, energy expenditure research, GLP-1/GIP/glucagon receptor agonism studies
For Research Use Only. Not for human consumption. Not for veterinary use. Not approved by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.
Every vial includes a batch code — verify your lab results here.
